The Clinical Applications of Extended-Release Abuse-Deterrent Opioids
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Clinical Applications of Extended-Release Abuse-Deterrent Opioids
Authors
Keywords
Oxycodone, Oxymorphone, OxyContin, Opioid Formulation, Suboxone
Journal
CNS DRUGS
Volume 30, Issue 7, Pages 637-646
Publisher
Springer Nature
Online
2016-06-11
DOI
10.1007/s40263-016-0357-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone
- (2016) Srinivas Nalamachu et al. CURRENT MEDICAL RESEARCH AND OPINION
- Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets
- (2015) Tiffani D. Eisenhauer et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008–2013)
- (2015) Angela DeVeaugh-Geiss et al. JOURNAL OF PAIN
- Hydrocodone extended-release: Pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy
- (2015) Harry J. Gould et al. PHARMACOLOGICAL RESEARCH
- Acute Sensorineural Hearing Loss After Abuse of an Inhaled, Crushed Oxymorphone Extended-Release Tablet
- (2015) Lisa E. MacDonald et al. PHARMACOTHERAPY
- A Prospective Multicentre Study to Evaluate the Efficacy and Tolerability of Osmotic Release Oral System (Oros®) Hydromorphone in Opioid-Naive Cancer Patients: Results of the Korean South West Oncology Group Study
- (2015) Eun-Kee Song et al. Pain Research & Management
- Opioids for low back pain
- (2015) R. A. Deyo et al. BMJ-British Medical Journal
- Opioids for low back pain
- (2015) R. A. Deyo et al. BMJ-British Medical Journal
- Development and impact of prescription opioid abuse deterrent formulation technologies
- (2014) Louis Alexander et al. DRUG AND ALCOHOL DEPENDENCE
- Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study
- (2014) Richard L. Rauck et al. PAIN MEDICINE
- Antagonist Models for Treating Persons With Substance use Disorders
- (2014) George E. Woody Current Psychiatry Reports
- Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study
- (2014) Seong Hoon Shin et al. Cancer Research and Treatment
- Review of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulations
- (2014) Arshi Kizilbash et al. Journal of Pain Research
- A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
- (2014) Srinivas Nalamachu et al. Journal of Pain Research
- Current Topics in Opioid Therapy for Pain Management: Addressing the Problem of Abuse
- (2013) Frank E. Casty et al. CLINICAL DRUG INVESTIGATION
- Population Pharmacokinetic Analysis for Hydrocodone Following the Administration of Hydrocodone Bitartrate Extended-Release Capsules
- (2013) Murad R. Melhem et al. CLINICAL PHARMACOKINETICS
- Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives
- (2013) Joseph V. Pergolizzi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmaceutical Overdose Deaths, United States, 2010
- (2013) Christopher M. Jones et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations
- (2013) Shannon M. Smith et al. PAIN
- A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics
- (2013) Hye-Suk Han et al. SUPPORTIVE CARE IN CANCER
- Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain
- (2013) Martin Hale et al. Journal of Pain Research
- Validity testing of patient objections to acceptance of tamper-resistant opioid formulations
- (2013) Charles Argoff et al. Journal of Pain Research
- Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing
- (2013) Krishna Devarakonda et al. SpringerPlus
- Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose?
- (2012) Bernard Bannwarth DRUGS
- Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use?
- (2012) Laura M Lourenço et al. Expert Opinion on Drug Delivery
- Low absolute bioavailability of oral naloxone in healthy subjects
- (2012) Kevin Smith et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer Pain: Pooled Analysis of 11 Clinical Studies
- (2012) Srinivas R. Nalamachu et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to Tampering
- (2012) Steven P. Stanos et al. MAYO CLINIC PROCEEDINGS
- Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS®hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain
- (2012) Ute Richarz et al. Pain Practice
- The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
- (2012) Jeffrey A. Gudin Therapeutics and Clinical Risk Management
- The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone
- (2011) Beatrice Setnik et al. PAIN MEDICINE
- Clinical Outcomes during Opioid Titration following Initiation with or Conversion to Remoxy®, an Extended-Release Formulation of Oxycodone
- (2011) Carl L. Roland et al. POSTGRADUATE MEDICINE
- Meta-analysis of dropout rates in randomized controlled clinical trials
- (2011) M. Gehling et al. SCHMERZ
- Development of a New Type of Prolonged Release Hydrocodone Formulation Based on Egalet® ADPREM Technology Using In Vivo–In Vitro Correlation
- (2011) Pernille H. Hemmingsen et al. Pharmaceutics
- The Relative Bioavailability of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules (EMBEDA®) and an Extended Release Morphine Sulfate Capsule Formulation (KADIAN®) in Healthy Adults Under Fasting Conditions
- (2010) Franklin K Johnson et al. AMERICAN JOURNAL OF THERAPEUTICS
- Opioid Pharmacotherapy for Chronic Non-Cancer Pain in the United States: A Research Guideline for Developing an Evidence-Base
- (2010) C. Richard Chapman et al. JOURNAL OF PAIN
- Clinical Efficacy and Safety of Once-Daily Dosing of a Novel, Prolonged-Release Oral Morphine Tablet Compared With Twice-Daily Dosing of a Standard Controlled-Release Morphine Tablet in Patients With Cancer Pain: A Randomized, Double-Blind, Exploratory Crossover Study
- (2010) Derry Ridgway et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Opioids for cancer pain: the challenge of optimizing treatment
- (2010) Gérard E. Plante et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial
- (2009) O Löwenstein et al. EXPERT OPINION ON PHARMACOTHERAPY
- ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules in the Treatment of Chronic Pain of Osteoarthritis of the Hip or Knee: Pharmacokinetics, Efficacy, and Safety
- (2009) Nathaniel Katz et al. JOURNAL OF PAIN
- Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers
- (2008) Kevin Smith et al. CLINICAL THERAPEUTICS
- Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain
- (2008) K. Simpson et al. CURRENT MEDICAL RESEARCH AND OPINION
- A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation
- (2008) Winfried Meissner et al. EUROPEAN JOURNAL OF PAIN
- Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist
- (2008) Gery Schulteis et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started